Cited by 440Glioma Diagnosis and TreatmentRadiomics and Machine Learning in Medical ImagingBrain Tumor Detection and Classification

Identification of noninvasive imaging surrogates for brain tumor gene-expression modules

Open access
Diehn, Maximilian, Nardini, Christine, Wang, David S., McGovern, Susan, Jayaraman, Mahesh, Liang, Yu, Aldape, Kenneth, Cha, Soonmee +1 more·2008·Proceedings of the National Academy of Sciences

Abstract

Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor in adults. We combined neuroimaging and DNA microarray analysis to create a multidimensional map of gene-expression patterns in GBM that provided clinically relevant insights into tumor biology. Tumor contrast enhancement and mass effect predicted activation of specific hypoxia and proliferation gene-expression programs, respectively. Overexpression of EGFR, a receptor tyrosine kinase and potential therapeutic target, was also directly inferred by neuroimaging and was validated in an independent set of tumors by immunohistochemistry. Furthermore, imaging provided insights into the intratumoral distribution of gene-expression patterns within GBM. Most notably, an “infiltrative” imaging phenotype was identified that predicted patient outcome. Patients with this imaging phenotype had a greater tendency toward having multiple tumor foci and demonstrated significantly shorter survival than their counterparts. Our findings provide an in vivo portrait of genome-wide gene expression in GBM and offer a potential strategy for noninvasively selecting patients who may be candidates for individualized therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0801279105

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a subsequent study, an "infiltrative" imaging phenotype was associated with significantly shorter survival in patients with glioblastoma multiforme.

    “They found that an “infiltrative” imaging phenotype was associated with significantly shorter survival (54).”

    From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [54]

  • Seminal radiogenomic studies were the first to show a relationship between quantitative image features and gene expression patterns in patients with cancer.

    “Seminal radiogenomic studies were the first to show a relationship between quantitative image features and gene expression patterns in patients with cancer (40,54,55).”

    From Radiomics: Images Are More than Pictures, They Are Data (2016) · cites this paper as [54]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., Aldape, K., Cha, S., & Kuo, M. D.
Affiliations
  • Stanford Medicine (US)
  • *Department of Radiology and
  • The University of Texas MD Anderson Cancer Center (US)
  • Brown University (US)
  • University of California San Francisco Medical Center (US)
  • University of California San Diego Medical Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2008-04
Volume
105
Issue
13
Pages
5213-5218
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2141059777
Cited by
440
References
34
Citations by year
2026: 5 · 2025: 2 · 2024: 11 · 2023: 12 · 2022: 24 · 2021: 42 · 2020: 33 · 2019: 43 · 2018: 50 · 2017: 40 · 2016: 31 · 2015: 32 · 2014: 22 · 2013: 28 · 2012: 28
FWCI
5.67
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Radiological Society of North America
  • Bracco Diagnostics
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (NS045013, K23NS045013)
Topics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Life Sciences › Neuroscience › Neurology › Brain Tumor Detection and Classification
Keywords
glioblastoma, gene expression profiling, neuroimaging, EGFR overexpression, cell proliferation, tumor contrast enhancement, mass effect, intratumoral heterogeneity, patient survival prediction, non-invasive biomarkers, personalized treatment
MeSH terms
Brain Neoplasms, Humans, Magnetic Resonance Imaging, Neoplasm Invasiveness, Phenotype, Gene Expression Regulation, Neoplastic, Survival Rate, Treatment Outcome, Clinical Laboratory Techniques, Gene Expression Profiling, Gene Regulatory Networks, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review